International real-world study of DLL3 expression in patients with small cell lung cancer


Rojo F., Corassa M., Mavroudis D., Oz A. B. , Biesma B., Brcic L., ...Daha Fazla

LUNG CANCER, cilt.147, ss.237-243, 2020 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 147
  • Basım Tarihi: 2020
  • Doi Numarası: 10.1016/j.lungcan.2020.07.026
  • Dergi Adı: LUNG CANCER
  • Sayfa Sayıları: ss.237-243

Özet

Objectives: Expression of the Notch-family ligand delta-like protein 3 (DLL3), a potential therapeutic target in small cell lung cancer (SCLC), has not been assessed in the real-world setting. To identify the real-world utility of DLL3 as an SCLC therapeutic target, we performed the largest retrospective international noninterventional study to date to evaluate DLL3 prevalence in SCLC patients.